Prelude Therapeutics Incorporated (PRLD)

Prelude Therapeutics Statistics

Total Valuation

PRLD has a market cap or net worth of $40.73 million. The enterprise value is -$76.97 million.

Market Cap	40.73M
Enterprise Value	-76.97M

Important Dates

The last earnings date was Monday, March 10, 2025, after market close.

Earnings Date	Mar 10, 2025
Ex-Dividend Date	n/a

Share Statistics

PRLD has 55.15 million shares outstanding. The number of shares has increased by 25.60% in one year.

Current Share Class	42.30M
Shares Outstanding	55.15M
Shares Change (YoY)	+25.60%
Shares Change (QoQ)	+0.02%
Owned by Insiders (%)	6.34%
Owned by Institutions (%)	21.34%
Float	17.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.16
Forward PS	n/a
PB Ratio	0.28
P/TBV Ratio	0.29
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.30, with a Debt / Equity ratio of 0.14.

Current Ratio	5.30
Quick Ratio	5.21
Debt / Equity	0.14
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -69.01% and return on invested capital (ROIC) is -43.29%.

Return on Equity (ROE)	-69.01%
Return on Assets (ROA)	-38.54%
Return on Invested Capital (ROIC)	-43.29%
Return on Capital Employed (ROCE)	-93.22%
Revenue Per Employee	$54,688
Profits Per Employee	-$993,539
Employee Count	131
Asset Turnover	0.03
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -82.88% in the last 52 weeks. The beta is 1.42, so PRLD's price volatility has been higher than the market average.

Beta (5Y)	1.42
52-Week Price Change	-82.88%
50-Day Moving Average	1.01
200-Day Moving Average	2.62
Relative Strength Index (RSI)	36.72
Average Volume (20 Days)	158,447

Short Selling Information

The latest short interest is 3.10 million, so 5.63% of the outstanding shares have been sold short.

Short Interest	3.10M
Short Previous Month	3.15M
Short % of Shares Out	5.63%
Short % of Float	17.46%
Short Ratio (days to cover)	13.46

Income Statement

In the last 12 months, PRLD had revenue of $7.00 million and -$127.17 million in losses. Loss per share was -$1.68.

Revenue	7.00M
Gross Profit	7.00M
Operating Income	-139.71M
Pretax Income	-129.85M
Net Income	-127.17M
EBITDA	-137.94M
EBIT	-139.71M
Loss Per Share	-$1.68

Balance Sheet

The company has $133.61 million in cash and $18.03 million in debt, giving a net cash position of $115.59 million or $2.10 per share.

Cash & Cash Equivalents	133.61M
Total Debt	18.03M
Net Cash	115.59M
Net Cash Per Share	$2.10
Equity (Book Value)	131.46M
Book Value Per Share	2.38
Working Capital	110.25M

Cash Flow

In the last 12 months, operating cash flow was -$102.89 million and capital expenditures -$764,000, giving a free cash flow of -$103.65 million.

Operating Cash Flow	-102.89M
Capital Expenditures	-764,000
Free Cash Flow	-103.65M
FCF Per Share	-$1.88

Margins

Gross Margin	100.00%
Operating Margin	-1,995.91%
Pretax Margin	-1,816.76%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

PRLD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.60%
Shareholder Yield	-25.60%
Earnings Yield	-329.30%
FCF Yield	-268.39%

Analyst Forecast

The average price target for PRLD is $4.50, which is 509.31% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.50
Price Target Difference	509.31%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	72.06%
EPS Growth Forecast (5Y)	-12.99%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PRLD has an Altman Z-Score of -3.85 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-3.85
Piotroski F-Score	1